Low Testosterone: FDA Panel Backs Limits on Drugs
April 3, 2026
The New York Times reports
that a panel of twenty medical experts voted for the Food and Drug Administration (FDA) to impose new limitations on the testosterone drug industry. The panel recommended that the agency tighten the labeling of these drugs so they are not prescribed to men who are only experiencing the effects of getting older, such as decreased energy and libido.
While the FDA is not required to do what the panel tells it to do, the agency usually follows the advice of such expert panels. Meanwhile there is increasing medical evidence that testosterone has serious side effects and can, in certain patients, cause serious injury including, potentially melanoma (serious skin cancer). JAMA Intern Med. 2014.
While the FDA is not required to do what the panel tells it to do, the agency usually follows the advice of such expert panels. Meanwhile there is increasing medical evidence that testosterone has serious side effects and can, in certain patients, cause serious injury including, potentially melanoma (serious skin cancer). JAMA Intern Med. 2014.
For questions about product liability for Low T (testosterone) drugs Click here to contact us for a confidential case review.

October 19, 2026
On 10/20/10 the Tennessee Supreme Court reinstated a jury verdict obtained by David Randolph Smith & Associates for the widow of a Tennessee Army National Guard sergeant who died in 2000. The jury had awarded $7.2 million in the Tennessee wrongful death lawsuit against River Park Hospital of McMinnville. The Tennessee Supreme Court’s reinstatement of the verdict resulted in a total award, with interest, of $10.7 million. Warren County court officials said the multimillion-dollar judgment was the largest amount awarded by a jury in county history at the time of its award.A copy of the opinion is available here.

October 19, 2026
Settlement in significant wrongful death case filed in Overton County, Tennessee in a mediation held in Nashville, Tennessee on July 25, 2005. The case involved the failure to treat and diagnose group b strep in a pregnant mother whose child was brain damaged and ultimately died from sepsis stemming from exposure to the group b strep during labor. The terms of the settlement are confidential.The firm is currently handling another group b strep medical malpractice case in state court in Tupelo, Mississippi.
